INTRODUCTION: There seems to be increasing evidence that @entity32 leads to @entity5 . For several @entity5 , an association with white blood cell (WBC) count has been reported. So far, no studies have been performed for @entity1697 and WBC. Therefore, the aim of the present study was to look at whether WBC count can be used as a prognostic marker for recurrence or @entity3 for @entity5 . MATERIAL AND METHODS: For 278 @entity1 with @entity5 , the preoperative WBC count was compared with the clinicopathological information: age, gender, T-status, N-status, recurrence, @entity3 , follow-up time, and time till recurrence or @entity3 appeared. RESULTS: Out of 278 @entity1 , 48 developed recurrence, 24 second @entity5 , 46 cervical @entity3 , and 14 distant @entity3 . The mean follow-up time was 35.97 months (range: 12-107 months). Significant Pearson correlation at the 0.05 level could be found for the T-status (0.046), but not for the N status (0.121). No significant correlation could be found between WBC count and the development of recurrence or @entity3 . CONCLUSION: In conclusion, our findings demonstrate that elevated WBC count does not seem to be a predictor for recurrence or for further @entity3 . Further research is recommended to investigate the WBC count in @entity1613 and in HPV positive @entity1 with oral SCC.

Evaluation of white blood cell count as a possible prognostic marker for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity32 :: ('MESH:D007249', 'Disease') :: ['inflammation'] @entity1697 :: ('MESH:D009062', 'Disease') :: ['cancer of the oral cavity'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancers', 'cancer', 'oral cancer', 'tumors'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases'] @entity1613 :: ('MESH:D011230', 'Disease') :: ['precancerous lesions']
@entity5 :: (MESH:D009369,Disease) :: ['oral cancer']
